Advertisement
GTBP vs MDGL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBP is a Buy and MDGL is a StrongBuy.
GTBP in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 10, 2026
GTBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 46 of 51 cases where GTBP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for GTBP just turned positive on October 08, 2026. Looking at past instances where GTBP's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.
Following a +14.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where GTBP advanced for three days, in 168 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GTBP as a result. In 103 of 112 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GTBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GTBP entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.235) is normal, around the industry mean (3.498). P/E Ratio (0.034) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. GTBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GTBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
MDGL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for MDGL turned positive on November 09, 2026. Looking at past instances where MDGL's MACD turned positive, the stock continued to rise in 30 of 39 cases over the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MDGL's RSI Oscillator exited the oversold zone, 26 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 65 cases where MDGL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +1.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDGL advanced for three days, in 219 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
MDGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for MDGL moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for MDGL entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.630) is normal, around the industry mean (3.498). P/E Ratio (-28.565) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (9.443) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. MDGL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
GTBP | MDGL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 24 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 90 | 72 | |
P/E GROWTH RATING 1..100 | 1 | 17 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDGL's Valuation (15) in the Pharmaceuticals Other industry is somewhat better than the same rating for GTBP (68) in the null industry. This means that MDGL’s stock grew somewhat faster than GTBP’s over the last 12 months.
MDGL's Profit vs Risk Rating (24) in the Pharmaceuticals Other industry is significantly better than the same rating for GTBP (100) in the null industry. This means that MDGL’s stock grew significantly faster than GTBP’s over the last 12 months.
MDGL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as GTBP (100) in the null industry. This means that MDGL’s stock grew similarly to GTBP’s over the last 12 months.
MDGL's Price Growth Rating (72) in the Pharmaceuticals Other industry is in the same range as GTBP (90) in the null industry. This means that MDGL’s stock grew similarly to GTBP’s over the last 12 months.
GTBP's P/E Growth Rating (1) in the null industry is in the same range as MDGL (17) in the Pharmaceuticals Other industry. This means that GTBP’s stock grew similarly to MDGL’s over the last 12 months.
| GTBP | MDGL | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 90% | N/A |
| MACD ODDS (%) | 3 days ago 75% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| Advances ODDS (%) | about 1 month ago 82% | 16 days ago 75% |
| Declines ODDS (%) | 2 days ago 90% | 6 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 70% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GTBP’s FA Score shows that 1 FA rating(s) are green while MDGL’s FA Score has 3 green FA rating(s).
- GTBP’s FA Score: 1 green, 4 red.
- MDGL’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GTBP’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 5 bullish TA indicator(s).
- GTBP’s TA Score: 4 bullish, 3 bearish.
- MDGL’s TA Score: 5 bullish, 3 bearish.
Price Growth
GTBP (@Biotechnology) experienced а -24.86% price change this week, while MDGL (@Biotechnology) price change was +9.15% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
GTBP is expected to report earnings on Nov 13, 2026.
MDGL is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
GTBP and
Correlation & Price change
A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with SLGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then SLGL could also see price increases.
| Ticker / NAME | Correlation To GTBP | 1D Price Change % | ||
|---|---|---|---|---|
| GTBP | 100% | -8.33% | ||
| SLGL - GTBP | 33% Loosely correlated | -0.39% | ||
| AMRN - GTBP | 33% Poorly correlated | +0.09% | ||
| MDGL - GTBP | 32% Poorly correlated | -0.04% | ||
| VKTX - GTBP | 31% Poorly correlated | -1.14% | ||
| XBIO - GTBP | 31% Poorly correlated | -1.64% | ||
More | ||||
MDGL and
Correlation & Price change
A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ALXO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ALXO could also see price increases.
| Ticker / NAME | Correlation To MDGL | 1D Price Change % | ||
|---|---|---|---|---|
| MDGL | 100% | -0.04% | ||
| ALXO - MDGL | 56% Loosely correlated | -13.62% | ||
| LCTX - MDGL | 43% Loosely correlated | -3.70% | ||
| CVM - MDGL | 43% Loosely correlated | +4.44% | ||
| VOR - MDGL | 42% Loosely correlated | -2.10% | ||
| CLLS - MDGL | 40% Loosely correlated | -0.89% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CLOC | 24.95 | 0.01 | +0.02% |
| AAM Crescent CLO ETF (CLOC) | |||
| FCAL | 48.03 | -0.26 | -0.54% |
| First Trust California Municipal High Income ETF (FCAL) | |||
| BOUT | 39.45 | -0.24 | -0.61% |
| CapForce IBD Breakout Opportunities ETF (BOUT) | |||
| VOOG | 79.31 | -0.67 | -0.84% |
| Vanguard S&P 500 Growth ETF (VOOG) | |||
| BBEM | 69.62 | -0.81 | -1.15% |
| JPMorgan BetaBuilders Emerging Markets Equity ETF (BBEM) | |||